Trials / Completed
CompletedNCT04257604
A Study of Perampanel as Add-on Therapy in Adult and Adolescent Participants With Focal Seizures
A Multicenter, Prospective, Real-life Observational Study of Perampanel as Add-on Therapy in Adult and Adolescent Patients With Focal Seizures (A Mirroring Clinical Practice Study of Perampanel in Adults and Adolescents) (The AMPA Study)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 243 (actual)
- Sponsor
- Eisai Limited · Industry
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of the present study will be to assess the effectiveness of add-on perampanel in participants with focal seizures in a real-life clinical setting.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Perampanel | Perampanel tablets. |
Timeline
- Start date
- 2016-01-03
- Primary completion
- 2019-04-30
- Completion
- 2019-04-30
- First posted
- 2020-02-06
- Last updated
- 2020-02-06
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04257604. Inclusion in this directory is not an endorsement.